Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5387 ARTÍCULOS , VIENDO DEL 1996 AL 2010

Diagnosis of Aicardi-Goutières Syndrome in Adults: A Case Series

Videira G, Malaquias MJ, Laranjinha I, Martins R, Taipa R, Magalhães M.

Mov Disord Clin Pract. 2020 Feb 17;7(3):303-307. doi: 10.1002/mdc3.12903. eCollection 2020 Apr.

Catheter Access Port (Computed Tomography) Myelography in Intrathecal Drug Delivery Troubleshooting: A Case Series of 70 Procedures

Delhaas EM, Harhangi BS, Frankema SPG, Huygen FJPM, van der Lugt A.

Neuromodulation. 2020 Oct;23(7):949-960. doi: 10.1111/ner.13153. Epub 2020 Apr 8.

IRF2BPL mutation causes nigrostriatal degeneration presenting with dystonia, spasticity and keratoconus

Prilop L, Buchert R, Woerz S, Gerloff C, Haack TB, Zittel S.

Parkinsonism Relat Disord. 2020 Oct;79:141-143. doi: 10.1016/j.parkreldis.2020.03.030. Epub 2020 Apr 9.

The Impact of Intrathecal Baclofen Therapy on Health-related Quality of Life for Children with Marked Hypertonia

Stewart K, Copeland L, Lewis J.

Dev Neurorehabil. 2020 Nov;23(8):542-547. doi: 10.1080/17518423.2020.1753841. Epub 2020 Apr 27.

[Spasticity management: an interprofessional evaluation]

Carda S, Vuadens P, Van Den Keybus K, Diserens K.

Rev Med Suisse. 2020 May 6;16(692):904-906.

Health-Related Quality of Life Outcomes from Botulinum Toxin Treatment in Spasticity

Roncoroni LP, Weiss D, Hieber L, Sturm J, Börtlein A, Mayr I, Appy M, Kühnler B, Buchthal J, Dippon C, Arnold G, Wächter T.

Toxins (Basel). 2020 May 4;12(5):292. doi: 10.3390/toxins12050292.

FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia

Spiegel LL, Ostrem JL, Bledsoe IO.

Toxins (Basel). 2020 May 17;12(5):332. doi: 10.3390/toxins12050332.

Dystonia as initial presentation of compound heterozygous GBA2 mutations: Expanding the phenotypic spectrum of SPG46

Kloth K, Cozma C, Bester M, Gerloff C, Biskup S, Zittel S.

Eur J Med Genet. 2020 Sep;63(9):103992. doi: 10.1016/j.ejmg.2020.103992. Epub 2020 Jun 24.

Dentate nucleus as target for deep brain stimulation in dystono-dyskinetic syndromes

Nicholson CL, Coubes P, Poulen G.

Neurochirurgie. 2020 Aug;66(4):258-265. doi: 10.1016/j.neuchi.2020.04.132. Epub 2020 Jul 2.

Botulinum Toxin and Neuronal Regeneration after Traumatic Injury of Central and Peripheral Nervous System

Luvisetto S.

Toxins (Basel). 2020 Jul 2;12(7):434. doi: 10.3390/toxins12070434.

Baclofen Toxicity in Children With Acute Kidney Injury: Case Reports and Review of the Literature

Mishaal RA, Lanphear NE, Armarnik E, van Rensburg ER, Matsell DG.

Child Neurol Open. 2020 Jun 24;7:2329048X20937113. doi: 10.1177/2329048X20937113. eCollection 2020 Jan-Dec.

Clinical and Molecular Features of Early Infantile Niemann Pick Type C Disease

Seker Yilmaz B, Baruteau J, Rahim AA, Gissen P.

Int J Mol Sci. 2020 Jul 17;21(14):5059. doi: 10.3390/ijms21145059.

Intrathecal Baclofen for Hypertonia Secondary to Glutaric Aciduria Type I

Frenkel M, Meyer EJ, Stadler JA 3rd.

Cureus. 2020 Jun 25;12(6):e8818. doi: 10.7759/cureus.8818.

Delayed Diagnoses of SGCE Myoclonus-Dystonia

Varga MG, Nand NP, LeDoux MS.

Tremor Other Hyperkinet Mov (N Y). 2020 Jul 28;10:23. doi: 10.5334/tohm.334.

Altered homodimer formation and increased iron accumulation in VAC14-related disease: Case report and review of the literature

Baumann H, Tunc S, Günther A, Münchau A, Lohmann K, Brüggemann N.

Parkinsonism Relat Disord. 2020 Nov;80:41-46. doi: 10.1016/j.parkreldis.2020.09.012. Epub 2020 Sep 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias